PT  - JOURNAL ARTICLE
AU  - Hand, Larry
ED  - Kosiborod, Mikhail
TI  - Ranolazine Provides Benefit over Placebo for T2DM Patients with Angina
DP  - 2013 May 01
TA  - MD Conference Express
PG  - 21--22
VI  - 13
IP  - 2
4099  - http://mdc.sagepub.com/content/13/2/21.short
4100  - http://mdc.sagepub.com/content/13/2/21.full
AB  - In a trial focused on the treatment of stable angina in patients with type 2 diabetes, ranolazine significantly reduced the frequency of angina episodes compared with placebo. This article presents the results of the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina study [TERISA; Kosiborod M et al. J Am Coll Cardiol 2013].